COVID-19 and liver disease: mechanistic and clinical perspectives
Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis
Objective To evaluate association between biomarkers and outcomes in COVID-19
hospitalised patients. COVID-19 pandemic has been a challenge. Biomarkers have always …
hospitalised patients. COVID-19 pandemic has been a challenge. Biomarkers have always …
COVID-19: Discovery, diagnostics and drug development
T Asselah, D Durantel, E Pasmant, G Lau… - Journal of …, 2021 - Elsevier
Summary Coronavirus disease 2019 (COVID-19) started as an epidemic in Wuhan in 2019,
and has since become a pandemic. Groups from China identified and sequenced the virus …
and has since become a pandemic. Groups from China identified and sequenced the virus …
Pathophysiological mechanisms of liver injury in COVID‐19
AD Nardo, M Schneeweiss‐Gleixner… - Liver …, 2021 - Wiley Online Library
The recent outbreak of coronavirus disease 2019 (COVID‐19), caused by the Severe Acute
Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) has resulted in a world‐wide …
Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) has resulted in a world‐wide …
Abnormal liver function tests in patients with COVID‐19: relevance and potential pathogenesis
Lipopolysaccharide Reverses Hepatic Stellate Cell Activation... : Hepatology Lipopolysaccharide
Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against …
Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against …
[PDF][PDF] Abnormal liver tests in COVID‐19: a retrospective observational cohort study of 1,827 patients in a major US hospital network
MA Hundt, Y Deng, MM Ciarleglio, MH Nathanson… - …, 2020 - Wiley Online Library
Background and Aims The coronavirus‐19 disease (COVID‐19) pandemic, caused by the
severe acute respiratory syndrome coronavirus 2 virus, is associated with significant …
severe acute respiratory syndrome coronavirus 2 virus, is associated with significant …
Systematic review with meta‐analysis: liver manifestations and outcomes in COVID‐19
AV Kulkarni, P Kumar, HV Tevethia… - Alimentary …, 2020 - Wiley Online Library
Background The incidence of elevated liver chemistries and the presence of pre‐existing
chronic liver disease (CLD) have been variably reported in COVID‐19. Aims To assess the …
chronic liver disease (CLD) have been variably reported in COVID‐19. Aims To assess the …
Pathophysiology of COVID-19: mechanisms underlying disease severity and progression
MK Bohn, A Hall, L Sepiashvili, B Jung… - …, 2020 - journals.physiology.org
The global epidemiology of coronavirus disease 2019 (COVID-19) suggests a wide
spectrum of clinical severity, ranging from asymptomatic to fatal. Although the clinical and …
spectrum of clinical severity, ranging from asymptomatic to fatal. Although the clinical and …
Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort
Objective Comorbid conditions are associated with poor prognosis in COVID-19. Registry
data show that patients with cirrhosis may be at high risk. However, outcome comparisons …
data show that patients with cirrhosis may be at high risk. However, outcome comparisons …
Risk factors of severe COVID-19: a review of host, viral and environmental factors
The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …
asymptomatic infections to severe disease and death. Understanding the risk factors of …